MARCUS ($MCS) posted quarterly earnings results on Friday, October 31st. The company reported earnings of $0.42 per share, missing estimates of $0.53 by $0.11. The company also reported revenue of $210,150,000, missing estimates of $217,147,475 by $-6,997,475.
You can see Quiver Quantitative's $MCS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MARCUS Insider Trading Activity
MARCUS insiders have traded $MCS stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MCS stock by insiders over the last 6 months:
- MARK A GRAMZ (Pres., Marcus Theatres Corp*) sold 5,138 shares for an estimated $42,805
- MICHAEL READE EVANS (Pres., Marcus Hotels & Resorts) sold 934 shares for an estimated $7,720
- DIANE M GERSHOWITZ purchased 5,846 shares for an estimated $0
- GREGORY S MARCUS (President and CEO) sold 5,846 shares for an estimated $0
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MARCUS Hedge Fund Activity
We have seen 58 institutional investors add shares of MARCUS stock to their portfolio, and 81 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 180,083 shares (+45.9%) to their portfolio in Q2 2025, for an estimated $3,036,199
- SQUAREPOINT OPS LLC added 124,664 shares (+332.2%) to their portfolio in Q2 2025, for an estimated $2,101,835
- RENAISSANCE TECHNOLOGIES LLC removed 121,800 shares (-31.3%) from their portfolio in Q2 2025, for an estimated $2,053,548
- ORBIS ALLAN GRAY LTD added 114,556 shares (+9.1%) to their portfolio in Q2 2025, for an estimated $1,931,414
- MARSHALL WACE, LLP removed 110,761 shares (-33.5%) from their portfolio in Q2 2025, for an estimated $1,867,430
- ACADIAN ASSET MANAGEMENT LLC added 108,771 shares (+94.5%) to their portfolio in Q2 2025, for an estimated $1,833,879
- CUBIST SYSTEMATIC STRATEGIES, LLC removed 105,364 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,776,437
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MARCUS Analyst Ratings
Wall Street analysts have issued reports on $MCS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Benchmark issued a "Buy" rating on 10/06/2025
- Barrington Research issued a "Outperform" rating on 09/23/2025
- Wedbush issued a "Outperform" rating on 07/18/2025
To track analyst ratings and price targets for MARCUS, check out Quiver Quantitative's $MCS forecast page.
MARCUS Price Targets
Multiple analysts have issued price targets for $MCS recently. We have seen 3 analysts offer price targets for $MCS in the last 6 months, with a median target of $24.0.
Here are some recent targets:
- Mike Hickey from Benchmark set a target price of $22.0 on 10/06/2025
- Patrick Sholl from Barrington Research set a target price of $25.0 on 09/23/2025
- Alicia Reese from Wedbush set a target price of $24.0 on 07/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
